This study was carried out to identify the possible effects of epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I) on cumulus expansion and nuclear maturation in bovine oocytes matured in vitro in serum-free media. Bovine follicular oocytes were matured in vitro and were then classified as cumulus cell-enclosed oocytes or denuded oocytes. They were then cultured for 24 h in TCM-199 (tissue culture medium-199) with EGF (50 ng ml−1), IGF-I (100 ng ml−1) and EGF plus IGF-I (50 and 100 ng ml−1, respectively). At the end of the culture period, the morphology of oocytes was evaluated for cumulus expansion and nuclear stage of maturation. In Expt 1, percentages of oocytes reaching maximum cumulus expansion were: 12.5% (control), 46.5% (EGF), 15.2% (IGF-I) and 52.8% (EGF plus IGF-I). In Expt 2, the respective rates of nuclear maturation were: 35.6%, 52.1%, 45.5% and 61.4% for cumulus cell-enclosed oocytes, and 35.3%, 46.6%, 45.4% and 42.5% for denuded oocytes; the same growth factor treatments were used in both cases. There was no significant effect of IGF-I on cumulus expansion. Maximum rates of cumulus expansion and nuclear maturation were obtained in the presence of both growth factors. These results lead to the following conclusions: (i) EGF, either alone or together with IGF-I, stimulates cumulus expansion; and (ii) both growth factors, acting alone or together, enhance nuclear maturation in oocytes surrounded by compact cumulus cells.
The effects of different combinations of epidermal growth factor (EGF) and insulin-like growth factor I (IGF-I) on cumulus expansion and meiotic maturation were examined in rabbit oocytes. Selected rabbit follicular oocytes were matured in vitro and were classified as cumulus–oocyte complexes or denuded oocytes. They were cultured in TCM 199, and were treated with growth factors at different concentrations: EGF at 0, 1, 10, 50 and 100 ng ml−1, IGF-I at 0, 50, 100 and 200 ng ml−1 and EGF plus IGF-I at 10 + 50; 10 + 100; 50 + 50 and 50 + 100 ng ml−1, respectively. After 6 h of culture, the oocytes were assessed for nuclear maturation and after 16 h of culture, for cumulus expansion and maturation stage. After culture for 6 h, the incidence of germinal vesicle breakdown was higher (P < 0.05) in all of the growth factor treatments tested compared with controls. After culture for 16 h, EGF enhanced the incidence of cumulus expansion at all of the concentrations tested. Cumulus expansion was greatest with 50 mg EGF ml−1 plus 100 ng IGF-I ml−1 (72.0% versus 2.4% in controls). Treatment with IGF-I significantly increased (P < 0.05) the incidence of metaphase II stage, and maximum stimulation occurred at 100 ng IGF-I ml−1 (84.5% versus 31.1% in controls). However, IGF-I did not affect cumulus expansion. When denuded oocytes were used, no positive effects on nuclear maturation rates were observed for any treatment. These results suggest that: (1) EGF, either alone or with IGF-I, stimulates cumulus expansion; (2) the addition of IGF-I or EGF plus IGF-I significantly enhances nuclear maturation in immature rabbit oocytes; and (3) this effect is mediated by the presence of cumulus cells.
Although high vitamin A may be teratogenic to the embryo, retinol has been shown to support oocyte developmental potential in vivo. Similarly, addition of retinol metabolite 9-cis-retinoic acid to in-vitro cultured oocytes could promote cytoplasmic maturation and subsequent early embryonic development. The objective of this study was to evaluate the effects of 5 nmol/l retinoic acid during in-vitro pre-maturation and maturation of bovine oocyte-cumulus complexes. Oocytes were aspirated from cows and either kept under meiotic arrest with 25 micro mol/l roscovitine and matured, or allowed to mature in permissive conditions (control). Cortical granule migration was analysed both after pre-maturation and maturation by fluorescent labelling of oocytes and subsequent laser confocal and fluorescence microscopy. Variables studied after in-vitro fertilization and culture in modified synthetic oviduct fluid were: (i) in-vitro embryonic development; (ii) ability of blastocysts to survive vitrification and warming; and (iii) differential cell counts measured by fluorescence microscopy. Although the presence of 5 nmol/l retinoic acid throughout in-vitro maturation was harmful, its presence during pre-maturation alone improved cytoplasmic granular migration, embryonic development, cryopreservation tolerance, total cell numbers and, as a consequence, embryonic quality. Pre-maturation in the presence of retinoic acid improves cytoplasmic competence of in-vitro matured bovine oocytes. Until more is known of the molecular mechanisms it would be irresponsible to use retinoic acid in maturation of human oocytes, especially in view of the narrow time window and possible species-specific differences in susceptibility and protection of the oocyte from epigenetic influences of retinol.